IE 2
Adresse : 73, Rue S. Torrents 13006 Marseille
Tel : 04 91 59 89 00
Résumé / Axes de recherche :
Addiction, Méthodologie, Qualité de vie, Cancer, Sida / VIH
Mots-clés :
Qualité de vie,
Sida / VIH,
Addiction
Publications récentes :
 Carrieri, M.P., et al., Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response : a 3-year follow-up study. Antivir Ther, 2003. 8(6) : p. 585-94.
Carrieri, M.P., et al., Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug Alcohol Depend, 2003. 72(1) : p. 13-21.
Carrieri, P., et al., Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2003. 32(1) : p. 38-47
Carrieri, M.P., et al., Reduced incidence of Kaposi’s sarcoma and of systemic non-hodgkin’s lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer, 2003. 103(1) : p. 142-4.
Bouhnik, A.D., et al., Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther, 2005. 10(1) : p. 53-61.
 Version à imprimer
|
